Sorbitol Side Effects

Sorbitol E420 is a clear, colorless, sugar alcohol. It functions as a humectant and sugar substitute. Sorbitol  is commonly used in shredded coconut, pet foods, candy, frozen desserts, low-calorie beverages, chewing gum, ice cream, and sugar-based confections. Though Sorbitol E420 is considered safe, some are convinced it has potentially dangerous health effects.

What Is Sorbitol E420?

Sorbitol E420 is a low calorie sweetener that has a good taste and is anti-cariogenic. It is good for producing kinds of low calorie, low sugar and low fat products. Sorbitol is also a moisturizer and stabilizer, besides being sweet. It can be used in confectionery, bakery foods, frozen dessert, biscuit, cake, sugar-coat and chocolate. It has one third less calories than sucrose, is anti-cariogenic, and anti-crystallization.

Possible Side Effects of Sorbitol E420

Although Sorbitol E420 generally regarded as a very safe and effective supplement, there can be some minor side effects. The side effects may:

  • Anal irritation; diarrhea; gas; nausea; stomach cramps.

GRAS Affirmation: Yes

Generally recognized as safe (GRAS) is an American Food and Drug Administration (FDA) designation that a chemical or substance added to food is considered safe by experts, and so is exempted from the usual Federal Food, Drug, and Cosmetic Act (FFDCA) food additive tolerance requirements. Sorbitol is considered safe.

Suggested Dosage

NA.

Special Populations Precaution

There is a lot of concern about diet and nutrition for these population, like Newborns, children, pregnant, sensitive to Sorbitol E420 populations. Better consult to your doctor if you would like to intake Sorbitol E420.

 

 

Related Research

1. Comparative study–efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. [J Pak Med Assoc. 2002 Sep] Author: Wali A, Mushtaq A, Nilofer.

2. Pharmacokinetics, pharmacodynamics, tolerability, and safety of a novel sorbitol dehydrogenase inhibitor in healthy participants. [J Clin Pharmacol. 2010 May] Author: Landau Z, Novotny MJ, Preston GM, Wright K, Freeman T, Dai H, Thompson J, Oates PJ, Calle RA.

Post Tags -